---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-061135"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T00:34:53.506858+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pacira BioSciences issues $287.5M convertible notes, repurchases $200M of 2025 notes and $25M stock

## Summary
- Issued $250.0M (plus $37.5M option) of 2.125% Convertible Senior Notes due 2029; net proceeds ~$278.4M.
- Used ~$191.4M to repurchase $200M aggregate principal of outstanding 0.750% convertible notes due 2025.
- Used ~$25.0M to repurchase 837,240 shares of common stock.
- Entered into capped call transactions to reduce potential dilution upon conversion, with cap price ~$53.75/share.
- Initial conversion price ~$39.56/share, representing ~32.5% premium over closing price of $29.86 on May 9, 2024.

## SEC filing metadata
- accession: 0001104659-24-061135
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000110465924061135/0001104659-24-061135-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000110465924061135/tm2414366d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-061135
- JSON: https://secwatch.observer/filing/0001104659-24-061135.json
- Plain text: https://secwatch.observer/filing/0001104659-24-061135.txt

## Key facts
- Debt Financings
  Pacira BioSciences, Inc. incurred convertible notes of up to an additional $37.5 million aggregate principal amount of the Notes with Jefferies LLC and J.P. Morgan Securities LLC, as representatives of the several initial purchasers at 2.125% per year maturing May 15, 2029.
  - Instrument: convertible notes
  - Principal: up to an additional $37.5 million aggregate principal amount of the Notes
  - Counterparty: Jefferies LLC and J.P. Morgan Securities LLC, as representatives of the several initial purchasers
  - Rate: 2.125% per year
  - Maturity: May 15, 2029
  - Event: incurrence
  source text: the Company granted the Initial Purchasers an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $37.5 million aggregate principal amount of the Notes on the same terms and conditions, which option was exercised in full by the Initial Purchasers on May 10, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000110465924061135/0001104659-24-061135-index.htm
- Material Agreements
  Pacira BioSciences, Inc. entered into Purchase Agreement with Jefferies LLC and J.P. Morgan Securities LLC, as representatives of the several initial purchasers named therein valued at $250.0 million principal amount of its 2.125% Convertible Senior Notes due 2029 (effective 2024-05-09).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: Jefferies LLC and J.P. Morgan Securities LLC, as representatives of the several initial purchasers named therein
  - Value: $250.0 million principal amount of its 2.125% Convertible Senior Notes due 2029
  - Effective: 2024-05-09
  source text: On May 9, 2024, Pacira BioSciences, Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) with Jefferies LLC and J.P. Morgan Securities LLC, as representatives of the several initial purchasers named therein (collectively, the “Initial Purchasers”), to issue and sell $250.0 million principal amount of its 2.125% Convertible Senior Notes due 2029
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000110465924061135/0001104659-24-061135-index.htm
- Material Agreements
  Pacira BioSciences, Inc. entered into Indenture with Computershare Trust Company, National Association, as trustee valued at 2.125% Convertible Senior Notes due 2029 (effective 2024-05-14).
  - Action: entry
  - Agreement: notes offering
  - Counterparty: Computershare Trust Company, National Association, as trustee
  - Value: 2.125% Convertible Senior Notes due 2029
  - Effective: 2024-05-14
  source text: On May 14, 2024, the Company entered into an Indenture relating to the issuance of the Notes (the “Indenture”), by and between the Company and Computershare Trust Company, National Association, as trustee (the “Trustee”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1396814/000110465924061135/0001104659-24-061135-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.